- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0016782

About Ryesino Pharmaceuticals Private Limited
Data last updated:
Ryesino Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 December 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85110UP1983PTC006356. Its GSTIN is 05AACCR7809R1ZR (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹8.28 Lakh. It is led by directors including Jaidesh Pal Wason (Managing Director) and Renu Wason.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 B Race Course Dehradun, Uttar Pradesh, India – 248001.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.49 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹43.98 Lakh (net margin 3%) and EBITDA of ₹54.04 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹76.45 Lakh and satisfied charges of ₹95 Lakh on record.
Ryesino Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0016782). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rinkomedicos.com.
Company details
CIN history
Ryesino Pharmaceuticals has one previous CIN (Corporate Identification Number): U85110UR1983PTC006356. The current CIN is U85110UP1983PTC006356, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110UP1983PTC006356 | Current |
| U85110UR1983PTC006356 | Previous |
Recognitions & Rankings of Ryesino Pharmaceuticals
Contact details
Ryesino Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its website is rinkomedicos.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3 B Race Course Dehradun, Uttar Pradesh, India – 248001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ryesino Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ryesino Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ryesino Pharmaceuticals Private Limited, buy the company report.
Financials of Ryesino Pharmaceuticals Private Limited
FY 2025 filings availableRyesino Pharmaceuticals Private Limited reported revenue of ₹14.49 Cr (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ryesino Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ryesino Pharmaceuticals Private Limited
Ryesino Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaidesh Pal Wason | Managing Director | 15 Dec 1983 | 42 Years 11 Months | Current |
| Renu Wason | Director | 18 Dec 1986 | 39 Years 10 Months | Current |
| Sachin Wason | Director | 27 Mar 2000 | 26 Years 7 Months | Current |
| Shagun Wason | Director | 01 Jun 2003 | 23 Years 5 Months | Current |
Peer comparison
Ryesino Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sredstva Regionale Chemie Private Limited | ₹14.53 Cr (FY 2024) | -10.0% | Mumbai, Maharashtra, India | |||
| Ryesino Pharmaceuticals Private Limitedthis company | ₹14.49 Cr (FY 2024) | ₹43.98 Lakh | 3% | 11.0% | Uttar Pradesh, India | |
| Elma Pharmaceuticals Private Limited | ₹14.46 Cr (FY 2025) | 1.0% | Thrissur, Kerala, India | |||
| Shree Raghupati Trading Private Limited | ₹14.44 Cr (FY 2024) | 11.0% | Lucknow, Uttar Pradesh, India | |||
| Bda Pharma Private Limited | ₹14.34 Cr (FY 2025) | -16.0% | Nagpur, Maharashtra, India |
To see the full peer comparison of Ryesino Pharmaceuticals Private Limited, buy the company report.
Auditor
Ryesino Pharmaceuticals Private Limited is audited by NEERAJNAGALIA for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NEERAJNAGALIA | FY 2022 | 070978 |
Shareholding
The shareholding of Ryesino Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ryesino Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Aug 2025 | 101155673 | Others | ₹11.95 Lakh | Open | |
| 18 Nov 2005 | 90281085 | State Bank of India | ₹60 Lakh | Open | |
| 08 Sep 2000 | 90272357 | State Bank of India | ₹4.5 Lakh | Open | |
| 22 May 2007 | 10053997 | State Bank of India | ₹95 Lakh | Satisfied |
To see the full charge records of Ryesino Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Ryesino Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ryesino Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ryesino Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCR7809R1ZR | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ryesino Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ryesino Pharmaceuticals Private Limited has 7 board changes on record since 1983: 4 appointments and 3 cessations. The latest: Meena Wason ceased to be Director on 15 Apr 2019.
5 earlier events are in the company report.
Frequently asked questions
Ryesino Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 December 1983 (43+ years old) and is registered under CIN U85110UP1983PTC006356.
Ryesino Pharmaceuticals has 4 current directors:
- Jaidesh Pal Wason - Managing Director
- Renu Wason - Director
- Sachin Wason - Director
- Shagun Wason - Director
The latest financial statements of Ryesino Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ryesino Pharmaceuticals is 05AACCR7809R1ZR, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ryesino Pharmaceuticals is U85110UP1983PTC006356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ryesino Pharmaceuticals was incorporated on 15 December 1983, making it 43+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Ryesino Pharmaceuticals by revenue are Sredstva Regionale Chemie Private Limited, Elma Pharmaceuticals Private Limited, Shree Raghupati Trading Private Limited, Bda Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Meena Wason ceased to be Director on 15 Apr 2019. Suresh Kumar Wason ceased to be Director on 15 Apr 2019. Tarun Wason ceased to be Director on 15 Apr 2019. Ryesino Pharmaceuticals has 7 board changes on record in total.
Yes, Ryesino Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0016782).
Ryesino Pharmaceuticals can be reached through the website rinkomedicos.com. Its registered office is in Uttar Pradesh, India.
The registered office of Ryesino Pharmaceuticals is at 3 B Race Course Dehradun, Uttar Pradesh, India – 248001.

